Study 1

A Double-Arm, Open Label, Phase III Study to Compare the Efficacy and Safety of SCENESSE®️ and Narrow-Band Ultraviolet B (NB-UVB) Light versus NB-UVB Light Alone in the Treatment of Vitiligo

Protocol Number: CUV105

Study 2

A Phase 3, Randomized, Double-Blind, 52-Week, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Nonsegmental Vitiligo

Protocol Number: INCB 54707-304

Study 3

A Phase 3, Randomized, PlaceboControlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who are Eligible for Systemic Therapy

Protocol Number: M19-044